Skip to main content

Free Content Exploring the determinants of treatment success for tuberculosis cases in Europe

Download Article:
(PDF 253.3330078125 kb)
SETTING: Pooled tuberculosis (TB) notifications from 13 European countries.

OBJECTIVE: To analyse the determinants of TB treatment success in different countries using individual data.

DESIGN: We asked 18 European countries with both outcome data and individual TB records to code outcomes for cases notified in 2000 and/or 2001. Cases completing treatment regardless of bacteriological proof of cure were considered successful.

RESULTS: Ten European Union countries and Iceland, Norway and Romania participated (72% response). Among 24660 TB cases (Romania excluded), ‘success’ was reported in 69% (country range 60–88%), 9% (0–11%) died, 1% (0–5%) failed, 4% defaulted or transferred (2–15%) and 12% (0–23%) were ‘unknown’. On logistic regression among cases with drug susceptibility results (n = 10303), ‘success’ was associated with younger age (>74 years: reference; 55–74 years: OR = 2.0, 95%CI 1.8–2.4; 35–54 years: 3.0, 95%CI 2.6–3.5; 15–34 years: 3.7, 95%CI 3.2–4.4; <15 years: 4.4, 95%CI 2.9–6.7), female sex (1.4, 95%CI 1.3–1.6), and no polyresistance (9.2, 95%CI 6.8–12.4). The Netherlands (1.6, 95%CI 1.3–2.0) and Slovakia (1.8, 95%CI 1.4–2.2) had higher success than Estonia (reference: lowest percentage success), while Austria was lower (0.64, 95%CI 0.52–0.78).

CONCLUSION: Preventing drug resistance, increasing adherence and improving care in the elderly should be priorities. Inter-country variations in treatment success suggest differences in the completeness of monitoring data and in the efficacy of national control programmes.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Europe; multivariate analysis; surveillance; treatment outcome; tuberculosis

Document Type: Regular Paper

Affiliations: 1: EuroTB, Institut de Veille Sanitaire, Saint-Maurice, France 2: Department of Infectious Diseases, Institut de Veille Sanitaire, Saint-Maurice, France

Publication date: 2005-11-01

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more